[HTML][HTML] Corticosteroid administration for viral pneumonia: COVID-19 and beyond

JW Yang, L Yang, RG Luo, JF Xu - Clinical Microbiology and Infection, 2020 - Elsevier
Background Corticosteroids are commonly used as adjuvant therapy for acute respiratory
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?

I Martin-Loeches, A Torres - European Respiratory Review, 2021 - Eur Respiratory Soc
Purpose Corticosteroids have been considered in medicine for a long time, and they are
broadly prescribed. In infectious diseases, corticosteroids have been regarded as a thread …

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19

F Camirand-Lemyre, L Merson… - JAMA Network …, 2023 - jamanetwork.com
Importance Research diversity and representativeness are paramount in building trust,
generating valid biomedical knowledge, and possibly in implementing clinical guidelines …

Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome

MA Matthay, KD Wick - The Journal of clinical investigation, 2020 - Am Soc Clin Investig
Although corticosteroids dampen the dysregulated immune system and sometimes are
prescribed as an adjunctive treatment for pneumonia, their effectiveness in the treatment of …

[HTML][HTML] Therapeutic application of corticosteroids in COVID‐19: a focus on optimum dose and duration of therapy

S Khiali, T Entezari‐Maleki - Journal of Clinical Pharmacology, 2021 - ncbi.nlm.nih.gov
The pandemic of coronavirus disease 2019 (COVID-19) has resulted in a global health
crisis. Pathophysiologically, the disease has the initial phase of viral replication that could be …

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

D Chaudhuri, K Sasaki, A Karkar, S Sharif… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …

Efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe COVID-19 pneumonia: a retrospective cohort study

Q Li, W Li, Y Jin, W Xu, C Huang, L Li, Y Huang… - Infectious diseases and …, 2020 - Springer
Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-
19 pneumonia. Methods A retrospective study based on propensity score matching was …

Effects of corticosteroid treatment for non-severe COVID-19 pneumonia: a propensity score-based analysis

M Yuan, X Xu, D Xia, Z Tao, W Yin, W Tan, Y Hu… - Shock, 2020 - journals.lww.com
Method: A retrospective cohort study based on propensity score analysis was designed to
explore the effects of corticosteroid on several clinical outcomes. Results: One hundred thirty …

Comparison of a target trial emulation framework vs Cox regression to estimate the association of corticosteroids with COVID-19 mortality

KL Hoffman, EJ Schenck, MJ Satlin… - JAMA Network …, 2022 - jamanetwork.com
Importance Communication and adoption of modern study design and analytical techniques
is of high importance for the improvement of clinical research from observational data …

Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis

JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar… - Jama, 2020 - jamanetwork.com
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …